Recent Advances in Burden of Multiple Medications in Elderly Patients with Multimorbidity

doi:10.12114/j.issn.1007-9572.2020.00.183

Abstract

Abstract: The burden of multiple medications is a foremost factor associated with medication beliefs，medication behavior and health outcomes in elderly patients with multimorbidity.So paying attention to the multiple medication burden may provide a new perspective for solving medication problems in this group.However，its research development is rarely reviewed.In this study，we gave a clear definition of medication burden，reviewed various studies about medication burden in elderly patients with multimorbidity，and summarized the recent research status，and analyzed general demographic data，complexity of medication regimens，medicine characteristics，patients' medication attitude and medication literacy，and family and social factors associated with medication burden，with a view to providing a scientific reference for reducing the burden of multiple medications in Chinese elderly patients with multimorbidity.
Elderly；Chronic disease；Medication therapy management；Burden of illness；Review

摘要： 老年慢病共存患者多重用药负担在影响其用药信念、用药行为和健康转归方面起着核心作用，关注老年慢病共存患者多重用药负担或可为解决其用药问题提供新角度，但鲜有研究对国内外老年慢病共存患者多重用药负担研究进展进行报道。本研究旨在明确患者用药负担的定义，并对国内外开展的有关老年慢病共存患者用药负担的研究进行梳理，总结其用药负担研究现状，并进一步分析其影响因素，即一般人口学资料、疾病药物治疗方案复杂性、药物本身特征、患者用药态度和药物素养以及家庭社会因素等，以期为降低我国老年慢病共存患者多重用药负担提供科学参考。

关键词: 老年人, 慢性病, 药物疗法管理, 疾病负担, 综述

WANG Yongli,ZHANG Zhenxiang,FU Bo. Recent Advances in Burden of Multiple Medications in Elderly Patients with Multimorbidity　[J]. Chinese General Practice, 2020, 23(15): 1853-1858. DOI: 10.12114/j.issn.1007-9572.2020.00.183.
王永利,张振香,符博. 老年慢病共存患者多重用药负担研究进展[J]. 中国全科医学, 2020, 23(15): 1853-1858. DOI: 10.12114/j.issn.1007-9572.2020.00.183.

References

［1］崔娟，毛凡，王志会.中国老年居民多种慢性病共存状况分析［J］．中国公共卫生，2016，32（1）：66-69．DOI：10.11847/zgggws2016-32-01-20.
CUI J，MAO F，WANG Z H.Comorbidity of common chronic diseases among the elderly in China［J］．Chinese Journal of Public Health，2016，32（1）：66-69．DOI：10.11847/zgggws2016-32-01-20.
［2］景跃军，李元.中国失能老年人构成及长期护理需求分析［J］．人口学刊，2014，36（2）：55-63．DOI：10.3969/j.issn.1004-129X.2014.02.006.
JING Y J，LI Y.Analysis on the make-up of China's disabled seniors and the demand for long-term care［J］．Population Journal，2014，36（2）：55-63．DOI：10.3969/j.issn.1004-129X.2014.02.006.
［3］ZHOU M G，WANG H D，ZENG X Y，et al．Mortality，morbidity，and risk factors in China and its Provinces，1990—2017：a systematic analysis for the Global Burden of Disease Study 2017［J］．Lancet，2019，394（10204）：1145-1158．DOI：10.1016/S0140-6736（19）30427-1.
［4］GBD Disease and Injury Incidence and Prevalence Collaborators.Global，regional，and national incidence，prevalence，and years lived with disability for 354 diseases and injuries for 195 countries and territories，1990—2017：a systematic analysis for the Global Burden of Disease Study 2017［J］.Lancet，2018，392（10159）：1789-1858.DOI：10.1016/S0140-6736（18）32279-7.
［5］冯娇，吕广梅.南京市江浦街道老年人用药情况调研［J］．中国卫生产业，2016，13（12）：167-169．DOI：10.16659/j.cnki.1672-5654.2016.12.167.
FENG J，LYU G M.Survey and research of medication in elderly in the Jiangpu street of Nanjing［J］．China Health Industry，2016，13（12）：167-169．DOI：10.16659/j.cnki.1672-5654.2016.12.167.
［6］赖小星，朱宏伟，霍晓鹏，等．老年多重用药患者用药依从性现状及其影响因素的研究［J］．中国护理管理，2016，16（12）：1638-1642．DOI：10.3969/j.issn.1672-1756.2016.12.012.
LAI X X，ZHU H W，HUO X P，et al．The current status and associated factors of medication compliance in the elderly undergoing polypharmacy［J］．Chinese Nursing Management，2016，16（12）：1638-1642．DOI：10.3969/j.issn.1672-1756.2016.12.012.
［7］HELD F P，BLYTH F，GNJIDIC D，et al．Association rules analysis of comorbidity and multimorbidity：the concord health and aging in men project［J］．J Gerontol A Biol Sci Med Sci，2016，71（5）：625-631．DOI：10.1093/gerona/glv181.
［8］MOHAMMED M A，MOLES R J，CHEN T F.Medication-related burden and patients' lived experience with medicine：a systematic review and metasynthesis of qualitative studies［J］．BMJ Open，2016，6（2）：e010035．DOI：10.1136/bmjopen-2015-010035.
［9］ETON D T，RIDGEWAY J L，EGGINTON J S，et al．Finalizing a measurement framework for the burden of treatment in complex patients with chronic conditions［J］．Patient Relat Outcome Meas，2015，6：117-126．DOI：10.2147/PROM.S78955.
［10］SAV A，SALEHI A，MAIR F S，et al．Measuring the burden of treatment for chronic disease：implications of a scoping review of the literature［J］．BMC Med Res Methodol，2017，17（1）：140．DOI：10.1186/s12874-017-0411-8.
［11］GIVEN B A，GIVEN C W，SIKORSKII A，et al．Medication burden of treatment using oral cancer medications［J］．Asia Pac J Oncol Nurs，2017，4（4）：275-282．DOI：10.4103/apjon.apjon_7_17.
［12］ABDULAH R，INSANI W N，DESTIANI D P，et al．Polypharmacy leads to increased prevalence of potentially inappropriate medication in the Indonesian geriatric population visiting primary care facilities［J］．Ther Clin Risk Manage，2018，4：1591-1597.
［13］HOVSTADIUS B，HOVSTADIUS K，ASTRAND B，et al．Increasing polypharmacy-an individual-based study of the Swedish population 2005—2008［J］．BMC Clin Pharmacol，2010，10：16．DOI：10.1186/1472-6904-10-16.
［14］Nice Medicines and Prescribing Centre.Medicines optimisation：the safe and effective use of medicines to enable the best possible outcomes［EB/OL］．（2015-09-25）［2019-08-19］．https：//www.nice.org.uk/guidance/ng5.
［15］GNJIDIC D，TINETTI M，ALLORE H G.Assessing medication burden and polypharmacy：finding the perfect measure［J］．Expert Rev Clin Pharmacol，2017，10（4）：345-347．DOI：10.1080/17512433.2017.1301206.
［16］ULLEY J，HARROP D，ALI A，et al．Deprescribing interventions and their impact on medication adherence in community-dwelling older adults with polypharmacy：a systematic review［J］．BMC Geriatr，2019，19（1）：15．DOI：10.1186/s12877-019-1031-4.
［17］FRIED T R，O'LEARY J，TOWLE V，et al．Health outcomes associated with polypharmacy in community-dwelling older adults：a systematic review［J］．J Am Geriatr Soc，2014，62（12）：2261-2272．DOI：10.1111/jgs.13153.
［18］HANLON J T，ZHAO X H，NAPLES J G，et al．Central nervous system medication burden and serious Falls in older nursing home residents［J］．J Am Geriatr Soc，2017，65（6）：1183-1189．DOI：10.1111/jgs.14759.
［19］JAMSEN K M，BELL J S，HILMER S N，et al．Effects of changes in number of medications and drug burden index exposure on transitions between frailty states and death：the concord health and ageing in men project cohort study［J］．J Am Geriatr Soc，2016，64（1）：89-95．DOI：10.1111/jgs.13877.
［20］RIZZUTO D，MELIS R J F，ANGLEMAN S，et al．Effect of chronic diseases and multimorbidity on survival and functioning in elderly adults［J］．J Am Geriatr Soc，2017，65（5）：1056-1060．DOI：10.1111/jgs.14868.
［21］REEVE E，WIESE M D，HENDRIX I，et al．People's attitudes，beliefs，and experiences regarding polypharmacy and willingness to deprescribe［J］．J Am Geriatr Soc，2013，61（9）：1508-1514．DOI：10.1111/jgs.12418.
［22］VANDER LAAN D M，ELDERS P J M，BOONS C C L M，et al．
The impact of cardiovascular medication use on patients' daily lives：a cross-sectional study［J］．Int J Clin Pharm，2018，40（2）：412-420．DOI：10.1007/s11096-018-0601-4.
［23］KRSKA J，MORECROFT C W，POOLE H，et al．Issues potentially affecting quality of life arising from long-term medicines use：a qualitative study［J］．Int J Clin Pharm，2013，35（6）：1161-1169．DOI：10.1007/s11096-013-9841-5.
［24］VILLALBA-MORENO A M，ALFARO-LARA E R，RODRíGUEZ-PéREZ A，et al．Association between drug burden index and functional and cognitive function in patients with multimorbidity［J］．Curr Pharm Des，2018，24（28）：3384-3391．DOI：10.2174/1381612824666180327154239.
［25］WRIGHT E A，STEINHUBL S R，JONES J B，et al．Medication burden in patients with acute coronary syndromes［J］．Am J Manag Care，2017，23（4）：e106-112.
［26］KRSKA J，MORECROFT C W，ROWE P H，et al．Measuring the impact of long-term medicines use from the patient perspective［J］．Int J Clin Pharm，2014，36（4）：675-678．DOI：10.1007/s11096-014-9970-5.
［27］SANTANA M J，HAVERMAN L，ABSOLOM K，et al．Training clinicians in how to use patient-reported outcome measures in routine clinical practice［J］．Qual Life Res，2015，24（7）：1707-1718．DOI：10.1007/s11136-014-0903-5.
［28］MOEN J，BOHM A，TILLENIUS T，et al．“I don't know how many of these ［medicines］ are necessary..” —— a focus group study among elderly users of multiple medicines［J］．Patient Educ Couns，2009，74（2）：135-141．DOI：10.1016/j.pec.2008.08.019.
［29］VAINIERI M，QUERCIOLI C，MACCARI M，et al．Reported experience of patients with single or multiple chronic diseases：empirical evidence from Italy［J］．BMC Health Serv Res，2018，18（1）：659．DOI：10.1186/s12913-018-3431-0.
［30］PARKINSON L，MAGIN P，LO T，et al．Measuring cumulative anticholinergic medicines burden in older Australian women［J］．Int J Popul Data Sci，2017，1（1）．DOI：10.23889/ijpds.v1i1.167.
［31］BURCU M，ALEXANDER G C，NG X，et al．Construct validity and factor structure of survey-based assessment of cost-related medication burden［J］．Med Care，2015，53（2）：199-206．DOI：10.1097/MLR.0000000000000286.
［32］HOPMAN P，HEINS M J，KOREVAAR J C，et al．Health care utilization of patients with multiple chronic diseases in the Netherlands：differences and underlying factors［J］．Eur J Intern Med，2016，35：44-50．DOI：10.1016/j.ejim.2016.08.025.
［33］SINO C G，SIETZEMA M，EGBERTS T C，et al．Medication management capacity in relation to cognition and self-management skills in older people on polypharmacy［J］．J Nutr Health Aging，2014，18（1）：44-49．DOI：10.1007/s12603-013-0359-2.
［34］HOPMAN P，HEINS M J，RIJKEN M，et al．Health care utilization of patients with multiple chronic diseases in the Netherlands：differences and underlying factors［J］．Eur J Intern Med，2015，26（3）：190-196．DOI：10.1016/j.ejim.2015.02.006.
［35］OBRELI NETO P R，NOBILI A，DE LYRA D P Jr，et al．Incidence and predictors of adverse drug reactions caused by drug-drug interactions in elderly outpatients：a prospective cohort study［J］．J Pharm Pharm Sci，2012，15（2）：332-343．DOI：10.18433/j3cc86.
［36］MODIG S，KRISTENSSON J，TROEIN M，et al．Frail elderly patients' experiences of information on medication.A qualitative study［J］．BMC Geriatr，2012，12：46．DOI：10.1186/1471-2318-12-46.
［37］ GOYAL P，BRYAN J，KNEIFATI-HAYEK J，et al．Association between functional impairment and medication burden in adults with heart failure［J］．J Am Geriatr Soc，2019，67（2）：284-291．DOI：10.1111/jgs.15654.
［38］SWAIN L，BARCLAY L.They've given me that many tablets，I'm bushed.I don't know where I'm going：Aboriginal and Torres Strait Islander peoples' experiences with medicines［J］．Aust J Rural Health，2013，21（4）：216-219．DOI：10.1111/ajr.12053.
［39］TORDOFF J，SIMONSEN K，THOMSON W M，et al．“It's just routine.” A qualitative study of medicine-taking amongst older people in New Zealand［J］．Pharm World Sci，2010，32（2）：154-161．DOI：10.1007/s11096-009-9361-5.
［40］KRSKA J，CORLETT S A，KATUSIIME B.Complexity of medicine regimens and patient perception of medicine burden［J］．Pharmacy（Basel），2019，7（1）：E18．DOI：10.3390/pharmacy7010018.
［41］POULIOT A，VAILLANCOURT R，STACEY D，et al．Defining and identifying concepts of medication literacy：an international perspective［J］．Res Social Adm Pharm，2018，14（9）：797-804．DOI：10.1016/j.sapharm.2017.11.005.
［42］BEUSCART J B，PETIT S，GAUTIER S，et al．Polypharmacy in older patients：identifying the need for support by a community pharmacist［J］．BMC Geriatr，2019，19（1）：277．DOI：10.1186/s12877-019-1276-y.
［43］刘菲，刘璎珞，陈茜，等．中国西部三省慢性病家庭用药负担调查［J］．中国卫生政策研究，2017，10（12）：54-58．DOI：10.3969/j.issn.1674-2982.2017.12.010.
LIU F，LIU Y L，CHEN Q，et al．Investigation of the affordability of chronic diseases drug use in families from three Provinces in Western China［J］．Chinese Journal of Health Policy，2017，10（12）：54-58．DOI：10.3969/j.issn.1674-2982.2017.12.010.
［44］王姬，应世栋，张文伟.肺结核患者疾病经济负担及其影响因素分析［J］．实用预防医学，2015，22（11）：1352-1354．DOI：10.3969/j.issn.1006-3110.2015.011.023.
［45］徐珊珊.糖尿病患者疾病经济负担影响因素及控制途径研究［D］．济南：山东大学，2013.
XU S S.Study on the influence factors of diabetes patients' disease economic burden and its control methods［D］．Jinan：Shandong University，2013.
［46］李兰翠，巫嘉陵，董虹.脑卒中经济负担的影响因素［J］.中国慢性病预防与控制，2016，24（3）：230-232.DOI：10.16386/j.cjpccd.issn.1004-6194.2016.03.021.　
LI L C，WU J L，DONG H.Influencing factors of economic burden of stroke［J］.Chinese Journal of Prevention and Control of Chronic Diseases，2016，24（3）：230-232.DOI：10.16386/j.cjpccd.issn.1004-6194.2016.03.021.